Lévy, R. Et Al. 2022. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2 .

Lévy, R., Gothe, F., Momenilandi, M., Magg, T., Materna, M., Peters, P., ... Raedler, J.(2022). Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2.

Lévy, Romain Et Al. "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency," JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2, 2022

Lévy, Romain Et Al. "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency." JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2, 2022

Lévy, R. Et Al. (2022) . "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency." JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2.

@article{article, author={Romain Lévy Et Al. }, title={Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency}, journal={JOURNAL OF EXPERIMENTAL MEDICINE}, year=2022}